Histologic studies have shown overexpression of PD-L1 in NK/T-cell lymphomas, providing a theoretical basis of targeting the PD1/PD-L1 axis in R/R diseases [89]. The gene discussed is CD274; the disease is T-cell non-Hodgkin lymphoma.